Cambridge Enterprise portfolio company Sphere Fluidics has been named one of the UK's top 50 disruptive SMEs by Real Business.
Sphere Fluidics named one of Britain's most disruptive businesses
It is great news that Cyto-Mine and our single cell analysis technology has been recognised by the broader UK business community as revolutionary." — Dr Rob Marchmont
The award was bestowed during the fourth annual Everline Future 50 competition in which organisers search the UK business landscape for companies that are 'breaking down barriers, creating innovative products and - most importantly - disrupting previously stagnant industries.'
Sphere Fluidics, which is commercialising lab-on-a-chip and picodroplet technology developed at the University of Cambridge, based on the research of Professors Chris Abell and Wilhelm Huch of the Department of Chemistry, has created unique products for use in single cell analysis and characterisation and also provides collaborative R&D services in this area.
Dr Rob Marchmont, Fluidic's Commerical Director, attended the awards ceremony and stated "It is great news that Cyto-Mine and our single cell analysis technology has been recognised by the broader UK business community as revolutionary."
Cambridge Enterprise exists to help University of Cambridge inventors, innovators and entrepreneurs make their ideas and concepts more commercially successful for the benefit of society, the UK economy, the inventors and the University.